Expert Rev of Obstet Gynecol. 2010;5(6):673-686. Each year worldwide, over 380,000 women die from pregnancy and pregnancy-related causes. If contraception were made available to unprotected women, ...

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...

Seattle, April 12, 2018--Evidence published today on a new contraceptive option is providing one possible answer to an age-old question in family planning: how to address barriers that make it ...

The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman’s risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three ...

A new contraceptive option provides a possible answer to an age-old question in family planning: how to address barriers that make it difficult for women to keep using contraception consistently.

DMPA SC does not protect against HIV infection (AIDS) or other sexually transmitted diseases. Injection site reactions such as injection site pain, injection site tenderness, injection site nodules, ...

Depot-medroxyprogesterone acetate is a commonly used injectable contraceptive that has been associated with an increased risk of HIV acquisition. This study compares effects of ...

DALLAS, Sept. 3 – Long-term use of a contraceptive injected once every three months impairs the arteries' ability to contract and expand, possibly increasing the risk for heart disease, according to ...